Publicação
The Bayer-Monsanto deal: one of the worst corporate deals ever
| Resumo: | This case describes the long-lasting acquisition process of Monsanto by the Germany-based multinational company Bayer, that was closed in June 2018. Given the rising skepticism and resistance regarding the deal on the part of both Bayer’s stakeholders and shareholders, the case will particularly focus on the rationale of the transaction and the motivation of the management board to keep their commitment to the acquisition while reflecting on the Corporate Governance of Bayer as well. Apart from the strategic reasons, the case also addresses the issues that arose in the course of the process and discusses whether the exceptionally high acquisition premium is justified or not. |
|---|---|
| Autores principais: | Ongun, Aylin |
| Assunto: | Mergers and acquisitions Corporate finance Synergies Corporate governance Stakeholder activism |
| Ano: | 2020 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | This case describes the long-lasting acquisition process of Monsanto by the Germany-based multinational company Bayer, that was closed in June 2018. Given the rising skepticism and resistance regarding the deal on the part of both Bayer’s stakeholders and shareholders, the case will particularly focus on the rationale of the transaction and the motivation of the management board to keep their commitment to the acquisition while reflecting on the Corporate Governance of Bayer as well. Apart from the strategic reasons, the case also addresses the issues that arose in the course of the process and discusses whether the exceptionally high acquisition premium is justified or not. |
|---|